BioSpace News Archive

Shorla Pharma Limited, a specialty pharmaceutical company, has announced that it has submitted, and the U.S. Food and Drug Administration has accepted for filing, its application for its SH-111 oncology drug designed to treat T-cell leukemia.

ChenMed, a national leader in primary care for underserved seniors, announced that Atlanta resident James B. “Buck” McCabe has joined its Board of Directors to help the company keep strengthening its culture in a period of sustained hyper growth.

Bristol Myers Squibb Receives Positive CHMP Opinion for Onureg ® (azacitidine tablets; CC-486) as Frontline Oral Maintenance Therapy for Adults with Acute Myeloid Leukemia in First Remission

Evotec SE (Frankfurt Stock Exchange; EVT, MDAX/TecDAX, ISIN: DE0005664809, WKN 566480) announces that today the Chairman of the Supervisory Board, Prof. Dr Wolfgang Plischke, has informed the Company of his decision to resign from his office in the Supervisory Board of Evotec SE effective as of the end of the Annual General Meeting on 15 June 2021

MindMed, a leading psychedelic medicine biotech company, announced that the Company’s subordinate voting shares have been approved for listing on The Nasdaq Capital Market.

Coherus BioSciences, Inc. (Nasdaq: CHRS) has received notice from immuno-oncology partner Junshi Biosciences that the Independent Data Monitoring Committee of the JUPITER-06 clinical trial has determined that toripalimab, an anti-PD-1 monoclonal antibody, in combination with paclitaxel/cisplatin as first-line treatment for patients with advanced esophageal squamous cell carcinoma (ESCC),

Medicago, a biopharmaceutical company headquartered in Quebec City is pleased to announce that Health Canada received for review the first portion of Medicago’s plant-derived COVID-19 vaccine candidate rolling submission on April 19, 2021.

Today, Vichy Laboratoires, a skincare brand committed to skin health science, announced that nine new clinical studies have been accepted by the American Academy of Dermatology for their annual meeting, held virtually from April 23-25.

Walgreens Boots Alliance, Inc. announced the early results and upsizing of the previously announced cash tender offer to purchase up to an amended Maximum Tender Amount of the outstanding senior notes identified in the table below, in the order of priority and subject to the Tender Caps shown in the table.

Reven Holdings, Inc. (“Reven”) is a privately held clinical stage biotechnology and pharmaceutical company dedicated to the discovery and development of novel treatment platforms for cancer, viral illnesses, including COVID-19 - and inflammatory disorders.